CPX-351, a lysosomal formulation of 7+3  Drug has been tested with significant survival

CPX-351, a lysosomal formulation of 7+3 Drug has been tested with significant survival

hematologydebates

2 years
39 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Amer M Zeidan, MBBS, CPX-351, a lysosomal formulation of 7+3 Drug has been tested with significant survival at Imedex Great Debates 2018.
Up Next Autoplay